Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Name: Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
License: Public Domain

PDS Biotechnology Corp.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

neoplasms

recurrent head and neck cancer, metastatic head and neck cancer, hpv positive oropharyngeal squamous cell carcinoma, neoplasms, head and neck, unresectable head and neck squamous cell carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 208444
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.